Rhythm Pharmaceuticals
RYTM
112.36
-4.44
-3.80%
Rhythm Pharmaceuticals
US · RYTM
#1874 by market cap
Listed 2017
112.36
-4.44
-3.80%
Periodic snapshot; not a real-time feed.
· 2026-11-20 19:30
Quant vs Street three independent views, side by side
StockVane factor grade
B
Momentum strategy signal
Hold
Analyst consensus
Buy
Mostly aligned, one view stands apart.
Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.
Analyst consensus 15 analysts
Buy
Avg price target 149.64 +33.2%
Price target rangecurrent 112.36
Low120.00
Avg149.64
High206.00
Buy 93%
Hold 7%
Sell 0%
Recent ratings (25)
| Date | Firm | Analyst | Rating | Target |
|---|---|---|---|---|
| 2026-11-06 | J.P. Morgan | -- | Buy | 142.00 |
| 2026-11-05 | CCORF | -- | Buy | 168.00 |
| 2026-11-05 | Citi | -- | Buy | 143.00 |
| 2026-11-04 | Wells Fargo | -- | Buy | 155.00 |
| 2026-11-04 | Citizens JMP | -- | Buy | 166.00 |
| 2026-11-04 | Morgan Stanley | -- | Buy | 146.00 |
| 2026-11-04 | Guggenheim | -- | Buy | 147.00 |
| 2026-11-03 | TD Cowen | -- | Buy | 130.00 |
| 2026-11-03 | BofA Securities | -- | Buy | 150.00 |
| 2026-11-03 | RBC Capital | -- | Buy | 159.00 |
| 2026-10-28 | Citi | -- | Buy | 143.00 |
| 2026-10-19 | Guggenheim | -- | Buy | 143.00 |
| 2026-10-15 | William Blair | -- | Buy | 206.00 |
| 2026-10-15 | J.P. Morgan | -- | Buy | 145.00 |
| 2026-10-14 | Citi | -- | Buy | 143.00 |
| 2026-10-12 | H.C. Wainwright | -- | Buy | 130.00 |
| 2026-10-09 | BofA Securities | -- | Buy | -- |
| 2026-10-08 | RBC Capital | -- | Buy | 159.00 |
| 2026-09-17 | Wolfe Research | -- | Buy | -- |
| 2026-09-15 | J.P. Morgan | -- | Buy | -- |
| 2026-09-14 | Leerink Partners | -- | Buy | 133.00 |
| 2026-09-14 | RBC Capital | -- | Buy | 155.00 |
| 2026-08-27 | Deutsche Bank | -- | Hold | 120.00 |
| 2026-08-24 | Morgan Stanley | -- | Buy | 150.00 |
| 2026-08-24 | Guggenheim | -- | Buy | 143.00 |
Price target trend monthly average, last 3 years
Earnings history price reaction on the day
| Period | Report date | Session | Options expected | Actual move |
|---|---|---|---|---|
| 2026/Q3 | 2026-11-03 | -- | ±10.53% | -7.49% (in line) |
| 2026/Q2 | 2026-08-04 | -- | ±11.25% | +2.92% (in line) |
| 2026/Q1 | 2026-05-05 | -- | ±11.16% | +7.86% (in line) |
| 2025/Q4 | 2026-02-26 | -- | ±14.17% | -1.09% (in line) |
| 2025/Q3 | 2025-11-04 | -- | ±9.68% | -7.69% (in line) |
| 2025/Q2 | 2025-08-05 | -- | ±9.45% | -1.85% (in line) |
| 2025/Q1 | 2025-05-07 | -- | ±12.54% | +3.06% (in line) |
| 2024/Q4 | 2025-02-26 | -- | ±10.15% | +4.49% (in line) |
| 2024/Q3 | 2024-11-05 | After close | ±8.36% | +11.38% (beat) |
| 2024/Q2 | 2024-08-06 | -- | ±25.32% | +0.02% (in line) |
| 2024/Q1 | 2024-05-07 | -- | ±8.75% | -10.32% (beat) |
| 2023/Q4 | 2024-02-22 | -- | ±15.48% | -9.73% (in line) |
"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.
Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.
Rhythm Pharmaceuticals discussion 0 comments